iShares U.S. Pharmaceuticals ETF (IHE) |
| 102.9 0.52 (0.51%) 07-27 16:00 |
| Open: | 102.73 |
| High: | 103.77 |
| Low: | 102.2201 |
| Volume: | 219,211 |
| Market Cap: | 1,144(M) |
| PE Ratio: | 28.82 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 121.20 |
| Resistance 1: | 103.77 |
| Pivot price: | 101.01 |
| Support 1: | 96.63 |
| Support 2: | 92.21 |
| 52w High: | 103.77 |
| 52w Low: | 64.94 |
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 24 Jul 2026
iShares U.S. Pharmaceuticals ETF (IHE) stock price, news, quote and history - Yahoo Finance Australia
Thu, 23 Jul 2026
ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook - TradingView
Wed, 22 Jul 2026
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF? - The Motley Fool
Sun, 19 Jul 2026
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now? - The Motley Fool
Sat, 18 Jul 2026
IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors? - The Motley Fool
Thu, 16 Jul 2026
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH? - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
